目錄:MedChemExpress LLC>>信號通路>> Cl-amidine hydrochloride | MCE
CAS | 1373232-26-8 | 純度 | 99.39% |
---|---|---|---|
分子量 | 347.24 | 分子式 | C??H??Cl?N?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 1 mg |
貨號 | HY-100574A | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
產(chǎn)品活性:Cl-amidine hydrochloride 是口服有效的 PAD 抑制劑,,其對 PAD1,、PAD3 和 PAD4 的 IC50 值分別為0.8 μM、 6.2 μM 和 5.9 μM,。Cl-amidine hydrochloride 可誘導(dǎo)癌細胞的凋亡,。Cl-amidine hydrochloride 可誘導(dǎo) miR-16 (miRNA-16, microRNA-16),引起細胞周期阻滯,。Cl-Amidine hydrochloride 可阻斷組蛋白 3 瓜氨酸化和中性粒細胞胞外陷阱的形成,,并提高敗血癥小鼠的存活率。
研究領(lǐng)域:Epigenetics | Apoptosis
作用靶點:Protein Arginine Deiminase | Apoptosis | MicroRNA
In Vitro: Cl-amidine is a bioavailable haloacetamidine-based compound that inhibits all the active PAD isozymes with near equal potency (kinact/KI=13,000 M-1?min-1 for PAD4).
Cl-amidine (0, 5, 10, 15, 20, 25, 50 μg/mL, 24 hours) induces apoptosis in TK6 lymphoblastoid cells and HT29 colon cancer cells in a dose-dependent manner. Interestingly, the colon cancer cell line (HT29) is relatively resistant to apoptosis caused by Cl-amidine.
Cl-Amidine prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model.
In Vivo: Cl-amidine (75 mg/kg, ip once daily) suppresses and treats DSS-induced colitis in mice.
Cl-amidine (5, 25, 75 mg/kg, oral gavage, once daily) leads to significant reductions in the histology scores dose-dependently.
相關(guān)產(chǎn)品:Covalent Screening Library Plus | Bioactive Compound Library Plus | Apoptosis Compound Library | Epigenetics Compound Library | Immunology/Inflammation Compound Library | Anti-Cancer Compound Library | Covalent Screening Library | Orally Active Compound Library | SY-5609 | BRD4 Inhibitor-18 | 8α-Tigloyloxyhirsutinolide 13-O-acetate | mmu-miR-211-5p mimic | mmu-miR-6384 mimic | hsa-miR-6821-3p mimic | hsa-miR-1296-5p mimic | mmu-miR-1953 mimic | mmu-miR-5624-5p mimic | rno-miR-336-5p mimic | mmu-miR-5132-3p mimic | AAPK-25 | mmu-miR-3093-3p mimic | Dutasteride-13C6 | hsa-miR-135b-5p mimic | hsa-miR-4646-5p mimic | hsa-miR-548al mimic | mmu-miR-133a-5p mimic | Oleic acid-13C | mmu-miR-6345 mimic | rno-miR-99a-3p mimic | hsa-miR-192-5p mimic | mmu-miR-707 mimic | hsa-miR-3689f mimic | Abacavir sulfate | mmu-let-7k mimic | Meloxicam-d3-1 | hsa-miR-532-3p mimic | hsa-miR-4637 mimic | Thailanstatin D
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物,;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng),;
• 產(chǎn)品種類涵蓋各種重組蛋白,,多肽,常用試劑盒 ,,更有 PROTAC,、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā),、生命科學(xué)等科研項目,;
• 提供虛擬篩選,離子通道篩選,,代謝組學(xué)分析檢測分析,,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴格的質(zhì)控,、驗證體系,;
• 提供 LC/MS、NMR,、HPLC,、手性分析、元素分析等各項質(zhì)檢報告,,確保產(chǎn)品的高純度,、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證,;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果,;
• 專業(yè)團隊跟蹤最新的制藥及生命科學(xué)研究進展,為您提供*新的活性化合物,;
• 與世界各大制藥公司及著名科研機構(gòu)建立了長期的合作,。